nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—gout—psoriatic arthritis	0.475	1	CtDrD
Naproxen—migraine—Prednisone—psoriatic arthritis	0.0959	0.341	CpDpCtD
Naproxen—osteoarthritis—Prednisone—psoriatic arthritis	0.0928	0.33	CpDpCtD
Naproxen—osteoarthritis—Methylprednisolone—psoriatic arthritis	0.0928	0.33	CpDpCtD
Naproxen—ALB—Auranofin—psoriatic arthritis	0.0343	0.186	CbGbCtD
Naproxen—SLCO1A2—Prednisolone—psoriatic arthritis	0.0224	0.121	CbGbCtD
Naproxen—PTGS2—Triamcinolone—psoriatic arthritis	0.0216	0.117	CbGbCtD
Naproxen—SLCO1A2—Prednisone—psoriatic arthritis	0.0211	0.115	CbGbCtD
Naproxen—PTGS2—Betamethasone—psoriatic arthritis	0.0186	0.101	CbGbCtD
Naproxen—SLCO1A2—Dexamethasone—psoriatic arthritis	0.0132	0.0715	CbGbCtD
Naproxen—ALB—Prednisone—psoriatic arthritis	0.0109	0.0592	CbGbCtD
Naproxen—PTGS2—Dexamethasone—psoriatic arthritis	0.0108	0.0586	CbGbCtD
Naproxen—SLCO1A2—Methotrexate—psoriatic arthritis	0.0106	0.0575	CbGbCtD
Naproxen—SLC22A6—Methotrexate—psoriatic arthritis	0.00642	0.0349	CbGbCtD
Naproxen—ALB—Methotrexate—psoriatic arthritis	0.00547	0.0297	CbGbCtD
Naproxen—CYP2C8—Dexamethasone—psoriatic arthritis	0.00526	0.0286	CbGbCtD
Naproxen—CYP2C9—Dexamethasone—psoriatic arthritis	0.00367	0.0199	CbGbCtD
Naproxen—PTGS2—Fluocinonide—Methylprednisolone—psoriatic arthritis	0.000206	0.159	CbGdCrCtD
Naproxen—PTGS2—Fluocinonide—Betamethasone—psoriatic arthritis	0.000203	0.156	CbGdCrCtD
Naproxen—PTGS2—Fluocinonide—Dexamethasone—psoriatic arthritis	0.000203	0.156	CbGdCrCtD
Naproxen—PTGS2—Fluocinonide—Triamcinolone—psoriatic arthritis	0.000198	0.153	CbGdCrCtD
Naproxen—PTGS2—Fluticasone Propionate—Methylprednisolone—psoriatic arthritis	0.000124	0.0957	CbGdCrCtD
Naproxen—PTGS2—Fluticasone Propionate—Betamethasone—psoriatic arthritis	0.000122	0.0942	CbGdCrCtD
Naproxen—PTGS2—Fluticasone Propionate—Dexamethasone—psoriatic arthritis	0.000122	0.0942	CbGdCrCtD
Naproxen—PTGS2—Fluticasone Propionate—Triamcinolone—psoriatic arthritis	0.00012	0.0921	CbGdCrCtD
Naproxen—Shock—Methylprednisolone—psoriatic arthritis	3.91e-05	0.000678	CcSEcCtD
Naproxen—Hepatobiliary disease—Methotrexate—psoriatic arthritis	3.9e-05	0.000676	CcSEcCtD
Naproxen—Nervous system disorder—Methylprednisolone—psoriatic arthritis	3.89e-05	0.000676	CcSEcCtD
Naproxen—Loss of consciousness—Betamethasone—psoriatic arthritis	3.89e-05	0.000675	CcSEcCtD
Naproxen—Loss of consciousness—Dexamethasone—psoriatic arthritis	3.89e-05	0.000675	CcSEcCtD
Naproxen—Epistaxis—Methotrexate—psoriatic arthritis	3.89e-05	0.000675	CcSEcCtD
Naproxen—Paraesthesia—Prednisolone—psoriatic arthritis	3.89e-05	0.000674	CcSEcCtD
Naproxen—Tachycardia—Triamcinolone—psoriatic arthritis	3.88e-05	0.000674	CcSEcCtD
Naproxen—Mental disorder—Prednisone—psoriatic arthritis	3.88e-05	0.000673	CcSEcCtD
Naproxen—Tachycardia—Methylprednisolone—psoriatic arthritis	3.88e-05	0.000673	CcSEcCtD
Naproxen—Skin disorder—Methylprednisolone—psoriatic arthritis	3.86e-05	0.000669	CcSEcCtD
Naproxen—Erythema—Prednisone—psoriatic arthritis	3.85e-05	0.000669	CcSEcCtD
Naproxen—Malnutrition—Prednisone—psoriatic arthritis	3.85e-05	0.000669	CcSEcCtD
Naproxen—Hyperhidrosis—Triamcinolone—psoriatic arthritis	3.85e-05	0.000668	CcSEcCtD
Naproxen—Agranulocytosis—Methotrexate—psoriatic arthritis	3.85e-05	0.000667	CcSEcCtD
Naproxen—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	3.84e-05	0.000666	CcSEcCtD
Naproxen—Convulsion—Dexamethasone—psoriatic arthritis	3.83e-05	0.000665	CcSEcCtD
Naproxen—Convulsion—Betamethasone—psoriatic arthritis	3.83e-05	0.000665	CcSEcCtD
Naproxen—Hypertension—Dexamethasone—psoriatic arthritis	3.82e-05	0.000663	CcSEcCtD
Naproxen—Hypertension—Betamethasone—psoriatic arthritis	3.82e-05	0.000663	CcSEcCtD
Naproxen—Myalgia—Dexamethasone—psoriatic arthritis	3.77e-05	0.000654	CcSEcCtD
Naproxen—Myalgia—Betamethasone—psoriatic arthritis	3.77e-05	0.000654	CcSEcCtD
Naproxen—Anxiety—Betamethasone—psoriatic arthritis	3.75e-05	0.000652	CcSEcCtD
Naproxen—Anxiety—Dexamethasone—psoriatic arthritis	3.75e-05	0.000652	CcSEcCtD
Naproxen—Discomfort—Dexamethasone—psoriatic arthritis	3.72e-05	0.000646	CcSEcCtD
Naproxen—Discomfort—Betamethasone—psoriatic arthritis	3.72e-05	0.000646	CcSEcCtD
Naproxen—Haemoglobin—Methotrexate—psoriatic arthritis	3.72e-05	0.000645	CcSEcCtD
Naproxen—Hypotension—Methylprednisolone—psoriatic arthritis	3.71e-05	0.000644	CcSEcCtD
Naproxen—Pain—Prednisolone—psoriatic arthritis	3.7e-05	0.000642	CcSEcCtD
Naproxen—Haemorrhage—Methotrexate—psoriatic arthritis	3.7e-05	0.000642	CcSEcCtD
Naproxen—Hepatitis—Methotrexate—psoriatic arthritis	3.7e-05	0.000642	CcSEcCtD
Naproxen—Pharyngitis—Methotrexate—psoriatic arthritis	3.67e-05	0.000637	CcSEcCtD
Naproxen—Urinary tract disorder—Methotrexate—psoriatic arthritis	3.65e-05	0.000634	CcSEcCtD
Naproxen—Vision blurred—Prednisone—psoriatic arthritis	3.63e-05	0.00063	CcSEcCtD
Naproxen—Urethral disorder—Methotrexate—psoriatic arthritis	3.63e-05	0.000629	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	3.63e-05	0.000629	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	3.62e-05	0.000628	CcSEcCtD
Naproxen—Anaphylactic shock—Betamethasone—psoriatic arthritis	3.61e-05	0.000627	CcSEcCtD
Naproxen—Anaphylactic shock—Dexamethasone—psoriatic arthritis	3.61e-05	0.000627	CcSEcCtD
Naproxen—Oedema—Dexamethasone—psoriatic arthritis	3.61e-05	0.000627	CcSEcCtD
Naproxen—Oedema—Betamethasone—psoriatic arthritis	3.61e-05	0.000627	CcSEcCtD
Naproxen—Insomnia—Triamcinolone—psoriatic arthritis	3.6e-05	0.000625	CcSEcCtD
Naproxen—Insomnia—Methylprednisolone—psoriatic arthritis	3.59e-05	0.000623	CcSEcCtD
Naproxen—Infection—Betamethasone—psoriatic arthritis	3.59e-05	0.000623	CcSEcCtD
Naproxen—Infection—Dexamethasone—psoriatic arthritis	3.59e-05	0.000623	CcSEcCtD
Naproxen—Ill-defined disorder—Prednisone—psoriatic arthritis	3.58e-05	0.00062	CcSEcCtD
Naproxen—Paraesthesia—Triamcinolone—psoriatic arthritis	3.57e-05	0.00062	CcSEcCtD
Naproxen—Feeling abnormal—Prednisolone—psoriatic arthritis	3.57e-05	0.000619	CcSEcCtD
Naproxen—Paraesthesia—Methylprednisolone—psoriatic arthritis	3.57e-05	0.000619	CcSEcCtD
Naproxen—Visual impairment—Methotrexate—psoriatic arthritis	3.57e-05	0.000619	CcSEcCtD
Naproxen—Anaemia—Prednisone—psoriatic arthritis	3.56e-05	0.000618	CcSEcCtD
Naproxen—Shock—Betamethasone—psoriatic arthritis	3.55e-05	0.000617	CcSEcCtD
Naproxen—Shock—Dexamethasone—psoriatic arthritis	3.55e-05	0.000617	CcSEcCtD
Naproxen—Dyspnoea—Triamcinolone—psoriatic arthritis	3.55e-05	0.000616	CcSEcCtD
Naproxen—Nervous system disorder—Betamethasone—psoriatic arthritis	3.54e-05	0.000615	CcSEcCtD
Naproxen—Nervous system disorder—Dexamethasone—psoriatic arthritis	3.54e-05	0.000615	CcSEcCtD
Naproxen—Thrombocytopenia—Betamethasone—psoriatic arthritis	3.54e-05	0.000614	CcSEcCtD
Naproxen—Thrombocytopenia—Dexamethasone—psoriatic arthritis	3.54e-05	0.000614	CcSEcCtD
Naproxen—Tachycardia—Dexamethasone—psoriatic arthritis	3.52e-05	0.000612	CcSEcCtD
Naproxen—Tachycardia—Betamethasone—psoriatic arthritis	3.52e-05	0.000612	CcSEcCtD
Naproxen—Angioedema—Prednisone—psoriatic arthritis	3.52e-05	0.000611	CcSEcCtD
Naproxen—Dyspepsia—Triamcinolone—psoriatic arthritis	3.5e-05	0.000608	CcSEcCtD
Naproxen—Erythema multiforme—Methotrexate—psoriatic arthritis	3.5e-05	0.000607	CcSEcCtD
Naproxen—Dyspepsia—Methylprednisolone—psoriatic arthritis	3.5e-05	0.000607	CcSEcCtD
Naproxen—Hyperhidrosis—Dexamethasone—psoriatic arthritis	3.49e-05	0.000606	CcSEcCtD
Naproxen—Hyperhidrosis—Betamethasone—psoriatic arthritis	3.49e-05	0.000606	CcSEcCtD
Naproxen—Malaise—Prednisone—psoriatic arthritis	3.48e-05	0.000603	CcSEcCtD
Naproxen—Vertigo—Prednisone—psoriatic arthritis	3.46e-05	0.000601	CcSEcCtD
Naproxen—Eye disorder—Methotrexate—psoriatic arthritis	3.46e-05	0.0006	CcSEcCtD
Naproxen—Syncope—Prednisone—psoriatic arthritis	3.46e-05	0.0006	CcSEcCtD
Naproxen—Tinnitus—Methotrexate—psoriatic arthritis	3.45e-05	0.000599	CcSEcCtD
Naproxen—Anorexia—Dexamethasone—psoriatic arthritis	3.44e-05	0.000597	CcSEcCtD
Naproxen—Anorexia—Betamethasone—psoriatic arthritis	3.44e-05	0.000597	CcSEcCtD
Naproxen—Urticaria—Prednisolone—psoriatic arthritis	3.44e-05	0.000597	CcSEcCtD
Naproxen—Cardiac disorder—Methotrexate—psoriatic arthritis	3.43e-05	0.000596	CcSEcCtD
Naproxen—Fatigue—Triamcinolone—psoriatic arthritis	3.43e-05	0.000596	CcSEcCtD
Naproxen—Fatigue—Methylprednisolone—psoriatic arthritis	3.42e-05	0.000594	CcSEcCtD
Naproxen—Pain—Triamcinolone—psoriatic arthritis	3.4e-05	0.000591	CcSEcCtD
Naproxen—Loss of consciousness—Prednisone—psoriatic arthritis	3.39e-05	0.000588	CcSEcCtD
Naproxen—Hypotension—Betamethasone—psoriatic arthritis	3.37e-05	0.000586	CcSEcCtD
Naproxen—Hypotension—Dexamethasone—psoriatic arthritis	3.37e-05	0.000586	CcSEcCtD
Naproxen—Angiopathy—Methotrexate—psoriatic arthritis	3.36e-05	0.000583	CcSEcCtD
Naproxen—Immune system disorder—Methotrexate—psoriatic arthritis	3.34e-05	0.00058	CcSEcCtD
Naproxen—Convulsion—Prednisone—psoriatic arthritis	3.34e-05	0.000579	CcSEcCtD
Naproxen—Mediastinal disorder—Methotrexate—psoriatic arthritis	3.33e-05	0.000579	CcSEcCtD
Naproxen—Hypertension—Prednisone—psoriatic arthritis	3.33e-05	0.000577	CcSEcCtD
Naproxen—Chills—Methotrexate—psoriatic arthritis	3.32e-05	0.000576	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	3.29e-05	0.000571	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	3.29e-05	0.000571	CcSEcCtD
Naproxen—Arthralgia—Prednisone—psoriatic arthritis	3.28e-05	0.000569	CcSEcCtD
Naproxen—Myalgia—Prednisone—psoriatic arthritis	3.28e-05	0.000569	CcSEcCtD
Naproxen—Feeling abnormal—Triamcinolone—psoriatic arthritis	3.28e-05	0.000569	CcSEcCtD
Naproxen—Feeling abnormal—Methylprednisolone—psoriatic arthritis	3.27e-05	0.000568	CcSEcCtD
Naproxen—Anxiety—Prednisone—psoriatic arthritis	3.27e-05	0.000567	CcSEcCtD
Naproxen—Alopecia—Methotrexate—psoriatic arthritis	3.27e-05	0.000567	CcSEcCtD
Naproxen—Insomnia—Dexamethasone—psoriatic arthritis	3.27e-05	0.000567	CcSEcCtD
Naproxen—Insomnia—Betamethasone—psoriatic arthritis	3.27e-05	0.000567	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	3.26e-05	0.000565	CcSEcCtD
Naproxen—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	3.25e-05	0.000564	CcSEcCtD
Naproxen—Paraesthesia—Dexamethasone—psoriatic arthritis	3.24e-05	0.000563	CcSEcCtD
Naproxen—Paraesthesia—Betamethasone—psoriatic arthritis	3.24e-05	0.000563	CcSEcCtD
Naproxen—Discomfort—Prednisone—psoriatic arthritis	3.24e-05	0.000563	CcSEcCtD
Naproxen—Mental disorder—Methotrexate—psoriatic arthritis	3.24e-05	0.000562	CcSEcCtD
Naproxen—Malnutrition—Methotrexate—psoriatic arthritis	3.22e-05	0.000559	CcSEcCtD
Naproxen—Erythema—Methotrexate—psoriatic arthritis	3.22e-05	0.000559	CcSEcCtD
Naproxen—Hypersensitivity—Prednisolone—psoriatic arthritis	3.19e-05	0.000553	CcSEcCtD
Naproxen—Dyspepsia—Dexamethasone—psoriatic arthritis	3.18e-05	0.000552	CcSEcCtD
Naproxen—Dyspepsia—Betamethasone—psoriatic arthritis	3.18e-05	0.000552	CcSEcCtD
Naproxen—Urticaria—Triamcinolone—psoriatic arthritis	3.16e-05	0.000549	CcSEcCtD
Naproxen—Urticaria—Methylprednisolone—psoriatic arthritis	3.15e-05	0.000547	CcSEcCtD
Naproxen—Body temperature increased—Triamcinolone—psoriatic arthritis	3.15e-05	0.000546	CcSEcCtD
Naproxen—Oedema—Prednisone—psoriatic arthritis	3.14e-05	0.000546	CcSEcCtD
Naproxen—Anaphylactic shock—Prednisone—psoriatic arthritis	3.14e-05	0.000546	CcSEcCtD
Naproxen—Abdominal pain—Methylprednisolone—psoriatic arthritis	3.14e-05	0.000545	CcSEcCtD
Naproxen—Decreased appetite—Betamethasone—psoriatic arthritis	3.14e-05	0.000545	CcSEcCtD
Naproxen—Decreased appetite—Dexamethasone—psoriatic arthritis	3.14e-05	0.000545	CcSEcCtD
Naproxen—Infection—Prednisone—psoriatic arthritis	3.12e-05	0.000542	CcSEcCtD
Naproxen—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	3.12e-05	0.000541	CcSEcCtD
Naproxen—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	3.12e-05	0.000541	CcSEcCtD
Naproxen—Fatigue—Dexamethasone—psoriatic arthritis	3.11e-05	0.00054	CcSEcCtD
Naproxen—Fatigue—Betamethasone—psoriatic arthritis	3.11e-05	0.00054	CcSEcCtD
Naproxen—Shock—Prednisone—psoriatic arthritis	3.09e-05	0.000537	CcSEcCtD
Naproxen—Pain—Betamethasone—psoriatic arthritis	3.09e-05	0.000536	CcSEcCtD
Naproxen—Pain—Dexamethasone—psoriatic arthritis	3.09e-05	0.000536	CcSEcCtD
Naproxen—Nervous system disorder—Prednisone—psoriatic arthritis	3.08e-05	0.000535	CcSEcCtD
Naproxen—Tachycardia—Prednisone—psoriatic arthritis	3.07e-05	0.000533	CcSEcCtD
Naproxen—Skin disorder—Prednisone—psoriatic arthritis	3.05e-05	0.00053	CcSEcCtD
Naproxen—Hyperhidrosis—Prednisone—psoriatic arthritis	3.04e-05	0.000528	CcSEcCtD
Naproxen—Vision blurred—Methotrexate—psoriatic arthritis	3.04e-05	0.000527	CcSEcCtD
Naproxen—Anorexia—Prednisone—psoriatic arthritis	3e-05	0.00052	CcSEcCtD
Naproxen—Ill-defined disorder—Methotrexate—psoriatic arthritis	2.99e-05	0.000519	CcSEcCtD
Naproxen—Anaemia—Methotrexate—psoriatic arthritis	2.98e-05	0.000517	CcSEcCtD
Naproxen—Feeling abnormal—Dexamethasone—psoriatic arthritis	2.98e-05	0.000516	CcSEcCtD
Naproxen—Feeling abnormal—Betamethasone—psoriatic arthritis	2.98e-05	0.000516	CcSEcCtD
Naproxen—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	2.95e-05	0.000512	CcSEcCtD
Naproxen—Gastrointestinal pain—Betamethasone—psoriatic arthritis	2.95e-05	0.000512	CcSEcCtD
Naproxen—Hypersensitivity—Triamcinolone—psoriatic arthritis	2.93e-05	0.000509	CcSEcCtD
Naproxen—Hypersensitivity—Methylprednisolone—psoriatic arthritis	2.93e-05	0.000508	CcSEcCtD
Naproxen—Malaise—Methotrexate—psoriatic arthritis	2.9e-05	0.000504	CcSEcCtD
Naproxen—Vertigo—Methotrexate—psoriatic arthritis	2.89e-05	0.000502	CcSEcCtD
Naproxen—Leukopenia—Methotrexate—psoriatic arthritis	2.88e-05	0.0005	CcSEcCtD
Naproxen—Urticaria—Betamethasone—psoriatic arthritis	2.87e-05	0.000498	CcSEcCtD
Naproxen—Urticaria—Dexamethasone—psoriatic arthritis	2.87e-05	0.000498	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	2.87e-05	0.000497	CcSEcCtD
Naproxen—Dizziness—Prednisolone—psoriatic arthritis	2.86e-05	0.000497	CcSEcCtD
Naproxen—Asthenia—Triamcinolone—psoriatic arthritis	2.86e-05	0.000496	CcSEcCtD
Naproxen—Body temperature increased—Dexamethasone—psoriatic arthritis	2.85e-05	0.000495	CcSEcCtD
Naproxen—Abdominal pain—Betamethasone—psoriatic arthritis	2.85e-05	0.000495	CcSEcCtD
Naproxen—Abdominal pain—Dexamethasone—psoriatic arthritis	2.85e-05	0.000495	CcSEcCtD
Naproxen—Body temperature increased—Betamethasone—psoriatic arthritis	2.85e-05	0.000495	CcSEcCtD
Naproxen—Asthenia—Methylprednisolone—psoriatic arthritis	2.85e-05	0.000494	CcSEcCtD
Naproxen—Insomnia—Prednisone—psoriatic arthritis	2.84e-05	0.000494	CcSEcCtD
Naproxen—Paraesthesia—Prednisone—psoriatic arthritis	2.82e-05	0.00049	CcSEcCtD
Naproxen—Pruritus—Triamcinolone—psoriatic arthritis	2.82e-05	0.000489	CcSEcCtD
Naproxen—Cough—Methotrexate—psoriatic arthritis	2.81e-05	0.000488	CcSEcCtD
Naproxen—Pruritus—Methylprednisolone—psoriatic arthritis	2.81e-05	0.000488	CcSEcCtD
Naproxen—Convulsion—Methotrexate—psoriatic arthritis	2.79e-05	0.000484	CcSEcCtD
Naproxen—Dyspepsia—Prednisone—psoriatic arthritis	2.77e-05	0.00048	CcSEcCtD
Naproxen—Arthralgia—Methotrexate—psoriatic arthritis	2.74e-05	0.000476	CcSEcCtD
Naproxen—Chest pain—Methotrexate—psoriatic arthritis	2.74e-05	0.000476	CcSEcCtD
Naproxen—Myalgia—Methotrexate—psoriatic arthritis	2.74e-05	0.000476	CcSEcCtD
Naproxen—Decreased appetite—Prednisone—psoriatic arthritis	2.73e-05	0.000474	CcSEcCtD
Naproxen—Rash—Prednisolone—psoriatic arthritis	2.73e-05	0.000474	CcSEcCtD
Naproxen—Dermatitis—Prednisolone—psoriatic arthritis	2.73e-05	0.000473	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	2.72e-05	0.000473	CcSEcCtD
Naproxen—Diarrhoea—Methylprednisolone—psoriatic arthritis	2.72e-05	0.000472	CcSEcCtD
Naproxen—Fatigue—Prednisone—psoriatic arthritis	2.71e-05	0.000471	CcSEcCtD
Naproxen—Headache—Prednisolone—psoriatic arthritis	2.71e-05	0.000471	CcSEcCtD
Naproxen—Discomfort—Methotrexate—psoriatic arthritis	2.71e-05	0.00047	CcSEcCtD
Naproxen—Constipation—Prednisone—psoriatic arthritis	2.69e-05	0.000467	CcSEcCtD
Naproxen—Confusional state—Methotrexate—psoriatic arthritis	2.65e-05	0.00046	CcSEcCtD
Naproxen—Dizziness—Triamcinolone—psoriatic arthritis	2.63e-05	0.000457	CcSEcCtD
Naproxen—Anaphylactic shock—Methotrexate—psoriatic arthritis	2.63e-05	0.000456	CcSEcCtD
Naproxen—Dizziness—Methylprednisolone—psoriatic arthritis	2.63e-05	0.000456	CcSEcCtD
Naproxen—Infection—Methotrexate—psoriatic arthritis	2.61e-05	0.000453	CcSEcCtD
Naproxen—Feeling abnormal—Prednisone—psoriatic arthritis	2.59e-05	0.00045	CcSEcCtD
Naproxen—Asthenia—Dexamethasone—psoriatic arthritis	2.59e-05	0.00045	CcSEcCtD
Naproxen—Asthenia—Betamethasone—psoriatic arthritis	2.59e-05	0.00045	CcSEcCtD
Naproxen—Nervous system disorder—Methotrexate—psoriatic arthritis	2.58e-05	0.000447	CcSEcCtD
Naproxen—Thrombocytopenia—Methotrexate—psoriatic arthritis	2.57e-05	0.000447	CcSEcCtD
Naproxen—Gastrointestinal pain—Prednisone—psoriatic arthritis	2.57e-05	0.000446	CcSEcCtD
Naproxen—Nausea—Prednisolone—psoriatic arthritis	2.57e-05	0.000446	CcSEcCtD
Naproxen—Pruritus—Betamethasone—psoriatic arthritis	2.55e-05	0.000443	CcSEcCtD
Naproxen—Pruritus—Dexamethasone—psoriatic arthritis	2.55e-05	0.000443	CcSEcCtD
Naproxen—Skin disorder—Methotrexate—psoriatic arthritis	2.55e-05	0.000443	CcSEcCtD
Naproxen—Hyperhidrosis—Methotrexate—psoriatic arthritis	2.54e-05	0.000441	CcSEcCtD
Naproxen—Vomiting—Triamcinolone—psoriatic arthritis	2.53e-05	0.000439	CcSEcCtD
Naproxen—Vomiting—Methylprednisolone—psoriatic arthritis	2.52e-05	0.000438	CcSEcCtD
Naproxen—Rash—Triamcinolone—psoriatic arthritis	2.51e-05	0.000436	CcSEcCtD
Naproxen—Dermatitis—Triamcinolone—psoriatic arthritis	2.51e-05	0.000435	CcSEcCtD
Naproxen—Anorexia—Methotrexate—psoriatic arthritis	2.51e-05	0.000435	CcSEcCtD
Naproxen—Rash—Methylprednisolone—psoriatic arthritis	2.5e-05	0.000435	CcSEcCtD
Naproxen—Dermatitis—Methylprednisolone—psoriatic arthritis	2.5e-05	0.000434	CcSEcCtD
Naproxen—Urticaria—Prednisone—psoriatic arthritis	2.5e-05	0.000434	CcSEcCtD
Naproxen—Headache—Triamcinolone—psoriatic arthritis	2.49e-05	0.000433	CcSEcCtD
Naproxen—Headache—Methylprednisolone—psoriatic arthritis	2.49e-05	0.000432	CcSEcCtD
Naproxen—Body temperature increased—Prednisone—psoriatic arthritis	2.49e-05	0.000431	CcSEcCtD
Naproxen—Abdominal pain—Prednisone—psoriatic arthritis	2.49e-05	0.000431	CcSEcCtD
Naproxen—Diarrhoea—Dexamethasone—psoriatic arthritis	2.47e-05	0.000429	CcSEcCtD
Naproxen—Diarrhoea—Betamethasone—psoriatic arthritis	2.47e-05	0.000429	CcSEcCtD
Naproxen—Hypotension—Methotrexate—psoriatic arthritis	2.46e-05	0.000426	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	2.39e-05	0.000416	CcSEcCtD
Naproxen—Dizziness—Betamethasone—psoriatic arthritis	2.39e-05	0.000414	CcSEcCtD
Naproxen—Dizziness—Dexamethasone—psoriatic arthritis	2.39e-05	0.000414	CcSEcCtD
Naproxen—Insomnia—Methotrexate—psoriatic arthritis	2.38e-05	0.000413	CcSEcCtD
Naproxen—Nausea—Triamcinolone—psoriatic arthritis	2.36e-05	0.00041	CcSEcCtD
Naproxen—Paraesthesia—Methotrexate—psoriatic arthritis	2.36e-05	0.00041	CcSEcCtD
Naproxen—Nausea—Methylprednisolone—psoriatic arthritis	2.36e-05	0.000409	CcSEcCtD
Naproxen—Dyspnoea—Methotrexate—psoriatic arthritis	2.34e-05	0.000407	CcSEcCtD
Naproxen—Somnolence—Methotrexate—psoriatic arthritis	2.34e-05	0.000406	CcSEcCtD
Naproxen—Hypersensitivity—Prednisone—psoriatic arthritis	2.32e-05	0.000402	CcSEcCtD
Naproxen—Dyspepsia—Methotrexate—psoriatic arthritis	2.31e-05	0.000402	CcSEcCtD
Naproxen—Vomiting—Betamethasone—psoriatic arthritis	2.3e-05	0.000398	CcSEcCtD
Naproxen—Vomiting—Dexamethasone—psoriatic arthritis	2.3e-05	0.000398	CcSEcCtD
Naproxen—Decreased appetite—Methotrexate—psoriatic arthritis	2.28e-05	0.000397	CcSEcCtD
Naproxen—Rash—Betamethasone—psoriatic arthritis	2.28e-05	0.000395	CcSEcCtD
Naproxen—Rash—Dexamethasone—psoriatic arthritis	2.28e-05	0.000395	CcSEcCtD
Naproxen—Dermatitis—Betamethasone—psoriatic arthritis	2.27e-05	0.000395	CcSEcCtD
Naproxen—Dermatitis—Dexamethasone—psoriatic arthritis	2.27e-05	0.000395	CcSEcCtD
Naproxen—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	2.27e-05	0.000394	CcSEcCtD
Naproxen—Fatigue—Methotrexate—psoriatic arthritis	2.27e-05	0.000393	CcSEcCtD
Naproxen—Headache—Betamethasone—psoriatic arthritis	2.26e-05	0.000393	CcSEcCtD
Naproxen—Headache—Dexamethasone—psoriatic arthritis	2.26e-05	0.000393	CcSEcCtD
Naproxen—Asthenia—Prednisone—psoriatic arthritis	2.26e-05	0.000392	CcSEcCtD
Naproxen—Pain—Methotrexate—psoriatic arthritis	2.25e-05	0.00039	CcSEcCtD
Naproxen—Pruritus—Prednisone—psoriatic arthritis	2.23e-05	0.000386	CcSEcCtD
Naproxen—Feeling abnormal—Methotrexate—psoriatic arthritis	2.17e-05	0.000376	CcSEcCtD
Naproxen—Diarrhoea—Prednisone—psoriatic arthritis	2.15e-05	0.000373	CcSEcCtD
Naproxen—Gastrointestinal pain—Methotrexate—psoriatic arthritis	2.15e-05	0.000373	CcSEcCtD
Naproxen—Nausea—Betamethasone—psoriatic arthritis	2.15e-05	0.000372	CcSEcCtD
Naproxen—Nausea—Dexamethasone—psoriatic arthritis	2.15e-05	0.000372	CcSEcCtD
Naproxen—Urticaria—Methotrexate—psoriatic arthritis	2.09e-05	0.000362	CcSEcCtD
Naproxen—Dizziness—Prednisone—psoriatic arthritis	2.08e-05	0.000361	CcSEcCtD
Naproxen—Abdominal pain—Methotrexate—psoriatic arthritis	2.08e-05	0.000361	CcSEcCtD
Naproxen—Body temperature increased—Methotrexate—psoriatic arthritis	2.08e-05	0.000361	CcSEcCtD
Naproxen—Vomiting—Prednisone—psoriatic arthritis	2e-05	0.000347	CcSEcCtD
Naproxen—Rash—Prednisone—psoriatic arthritis	1.98e-05	0.000344	CcSEcCtD
Naproxen—Dermatitis—Prednisone—psoriatic arthritis	1.98e-05	0.000344	CcSEcCtD
Naproxen—Headache—Prednisone—psoriatic arthritis	1.97e-05	0.000342	CcSEcCtD
Naproxen—Hypersensitivity—Methotrexate—psoriatic arthritis	1.94e-05	0.000336	CcSEcCtD
Naproxen—Asthenia—Methotrexate—psoriatic arthritis	1.89e-05	0.000327	CcSEcCtD
Naproxen—Nausea—Prednisone—psoriatic arthritis	1.87e-05	0.000324	CcSEcCtD
Naproxen—Pruritus—Methotrexate—psoriatic arthritis	1.86e-05	0.000323	CcSEcCtD
Naproxen—Diarrhoea—Methotrexate—psoriatic arthritis	1.8e-05	0.000312	CcSEcCtD
Naproxen—Dizziness—Methotrexate—psoriatic arthritis	1.74e-05	0.000302	CcSEcCtD
Naproxen—Vomiting—Methotrexate—psoriatic arthritis	1.67e-05	0.00029	CcSEcCtD
Naproxen—Rash—Methotrexate—psoriatic arthritis	1.66e-05	0.000288	CcSEcCtD
Naproxen—Dermatitis—Methotrexate—psoriatic arthritis	1.66e-05	0.000287	CcSEcCtD
Naproxen—Headache—Methotrexate—psoriatic arthritis	1.65e-05	0.000286	CcSEcCtD
Naproxen—Nausea—Methotrexate—psoriatic arthritis	1.56e-05	0.000271	CcSEcCtD
